Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese

Hypertension

Volumn 47, Issue 6, 2006, Pages 1147-1154

  Gu, Dongfeng ^a,b   Su, Shaoyong ^a,b   Ge, Dongliang ^a,c   Chen, Shufeng ^a   Huang, Jianfeng ^a   Li, Biao ^d   Chen, Runsheng ^d   Qiang, Boqin ^b  

^a FUWAI HOSPITAL   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Case control studies; Genetics; Hypertension, essential

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ALANINE; BETA 2 ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 4; G PROTEIN-COUPLED RECEPTOR KINASE 4; GLUTAMIC ACID; GLUTAMINE; PROTEIN SERINE THREONINE KINASE; TYROSINE 3 MONOOXYGENASE; VALINE;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; ESSENTIAL HYPERTENSION; EXPLORATORY RESEARCH; FEMALE; GENDER; GENE CONSTRUCT; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HYPOTHESIS; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS; ASIAN; GENETIC EPISTASIS; GENETICS; HYPERTENSION; MIDDLE AGED;

ALANINE; ALDOSTERONE SYNTHASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ADRENERGIC, BETA-2; TYROSINE 3-MONOOXYGENASE; VALINE;

EID: 33745000313     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000219041.66702.45     Document Type: Article

References (48)

1. Luft FC. Geneticism of essential hypertension. Hypertension. 2004;43:1155-1159.
2. Kaplan N. Clinical Hypertension. Philadelphia, PA: Lippincott Williams & Wilkins; 2002.
3. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet. 1999;22:239-247.
4. Timberlake DS, O'Connor DT, Parmer RJ. Molecular genetics of essential hypertension: recent results and emerging strategies. Curr Opin Nephrol Hypertens. 2001;10:71-79.
5. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation. 1998;97:1773-1779.
6. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation. 1998;97:1766-1772.
7. Higaki J, Baba S, Katsuya T, Sato N, Ishikawa K, Mannami T, Ogata J, Ogihara T. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita Study. Circulation. 2000;101:2060-2065.
8. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 1997;15:1579-1592.
9. Wang JG, Staessen JA. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol. 2000;410:289-302.
10. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol. 2000;20:484-492.
11. Harrap SB, Tzourio C, Cambien F, Poirier O, Raoux S, Chalmers J, Chapman N, Colman S, Leguennec S, MacMahon S, Neal B, Ohkubo T, Woodward M. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension. 2003;42:297-303.
12. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992;1:72-75.
13. Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, Jeffery S, Cappuccio FP, MacGregor GA, Sagnella GA. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens. 1996;10:31-35.
14. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med. 2002;34:88-95.
15. Siani A, Russo P, Paolo Cappuccio F, Iacone R, Venezia A, Russo O, Barba G, Iacoviello L, Strazzullo P. Combination of renin-angiotensin system polymorphisms is associated with altered renal sodium handling and hypertension. Hypertension. 2004;43:598-602.
16. Williams SM, Addy JH, Phillips JA, 3rd, Dai M, Kpodonu J, Afful J, Jackson H, Joseph K, Eason F, Murray MM, Epperson P, Aduonum A, Wong LJ, Jose PA, Felder RA. Combinations of variations in multiple genes are associated with hypertension. Hypertension. 2000;36:2-6.
17. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered. 2003;56:73-82.
18. Lim PO, Macdonald TM, Holloway C, Friel E, Anderson NH, Dow E, Jung RT, Davies E, Fraser R, Connell JM. Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J Clin Endocrinol Metab. 2002;87:4398-4402.
19. Esler M, Rumantir M, Kaye D, Jennings G, Hastings J, Socratous F, Lambert G. Sympathetic nerve biology in essential hypertension. Clin Exp Pharmacol Physiol. 2001;28:986-989.
20. DeQuattro V, Feng M. The sympathetic nervous system: the muse of primary hypertension. J Hum Hypertens. 2002;16(suppl 1):S64-S69.
21. Yang WJ, Huang JF, Yao CL, Fan ZJ, Ge DL, Gan WQ, Huang GY, Hui RT, Shen Y, Qiang BQ, Gu DF. Evidence for linkage and association of the markers near the LPL gene with hypertension in Chinese families. J Med Genet. 2003;40:e57.
22. Hamm HE. The many faces of G protein signaling. J Biol Chem. 1998;273:669-672.
23. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 1998;32:3-8.
24. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A. 2002;99:3872-3877.
25. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107-1112.
26. Breiman L FJ, Olshen RA, Stone CJ. Classification and Regression Trees. Belmont, CA: Chapman & Hall/CRC; 1984.
27. Friedman JH, Roosen CB. An introduction to multivariate adaptive regression splines. Stat Methods Med Res. 1995;4:197-217.
28. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, He J. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension. 2002;40:920-927.
29. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88:2460-2470.
30. Devlin B, Roeder K. Genomic control for association studies. Biometrics. 1999;55:997-1004.
31. Bacanu SA, Devlin B, Roeder K. The power of genomic control. Am J Hum Genet. 2000;66:1933-1944.
32. Abecasis GR, Cookson WO. GOLD-graphical overview of linkage disequilibrium. Bioinformatics. 2000;16:182-183.
33. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425-434.
34. Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol. 1995;52:39-44.
35. Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension. 1983;5:86-99.
36. Rockman HA, Koch WJ, Lefkowitz RJ. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. Am J Physiol. 1997;272:H1553-H1559.
37. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E. Positional genomic analysis identifies the β(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation. 2000;101:2877-2882.
38. Krushkal J, Ferrell R, Mockrin SC, Turner ST, Sing CF, Boerwinkle E. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation. 1999;99:1407-1410.
39. Busjahn A, Li GH, Faulhaber HD, Rosenthal M, Becker A, Jeschke E, Schuster H, Timmermann B, Hoehe MR, Luft FC. β-2 adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension. 2000;35:555-560.
40. Jose PA, Eisner GM, Felder RA. Dopamine and the kidney: a role in hypertension? Curr Opin Nephrol Hypertens. 2003;12:189-194.
41. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics. 2004;19:233-246.
42. Speirs HJ, Katyk K, Kumar NN, Benjafield AV, Wang WY, Morris BJ. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens. 2004;22:931-936.
43. Williams SM, Ritchie MD, Phillips JA, 3rd, Dawson E, Prince M, Dzhura E, Willis A, Semenya A, Summar M, White BC, Addy JH, Kpodonu J, Wong LJ, Felder RA, Jose PA, Moore JH. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered. 2004;57:28-38.
44. Xue C, Siragy HM. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension. 2005;46:584-590.
45. Culverhouse R, Suarez BK, Lin J, Reich T. A perspective on epistasis: limits of models displaying no main effect. Am J Hum Genet. 2002;70:461-471.
46. Zhang H, Bonney G. Use of classification trees for association studies. Genet Epidemiol. 2000;19:323-332.
47. York TP, Eaves LJ. Common disease analysis using Multivariate Adaptive Regression Splines (MARS): Genetic Analysis Workshop 12 simulated sequence data. Genet Epidemiol. 2001;21(suppl 1):S649-S654.
48. Cook NR, Zee RY, Ridker PM. Tree and spline based association analysis of gene-gene interaction models for ischemic stroke. Stat Med. 2004;23:1439-1453.